Was hoping for more out of the mono expansion.  2/3 PRs showed minimal durability &amp; progressed pretty quickly.  The combo colon PR is good news for sure.  Given how competitive melanoma is, the more responses they can show outside of that area, the better IMO.  $MDNAF